Integramed America, Inc. (NASDAQ: INMD) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $70.88 million versus the consensus estimate of $69.58 million.

For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.

Earnings